Genome Sequencing Market Size, Global Trends, Demand, Forecast to 2032

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Genome Sequencing Market Size Analysis

Global Genome Sequencing Market Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Reagents and Consumables
  1. By Value
4. Software and Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Next-Generation Sequencing
  1. By Value
3. Sanger Sequencing
  1. By Value
4. Third-Generation Sequencing
  1. By Value
5. Single-Molecule Real-Time Sequencing
  1. By Value
6. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Diagnostics
  1. By Value
3. Drug Discovery
  1. By Value
4. Precision Medicine
  1. By Value
5. Environmental Genomics
  1. By Value
6. Research
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Clinics
  1. By Value
3. Biotechnology and Pharmaceutical Companies
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Government
  1. By Value
6. Research Centers
  1. By Value
7. Academic and Government Institutes
  1. By Value
8. Others
  1. By Value

North America Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Reagents and Consumables
  1. By Value
4. Software and Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Next-Generation Sequencing
  1. By Value
3. Sanger Sequencing
  1. By Value
4. Third-Generation Sequencing
  1. By Value
5. Single-Molecule Real-Time Sequencing
  1. By Value
6. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Diagnostics
  1. By Value
3. Drug Discovery
  1. By Value
4. Precision Medicine
  1. By Value
5. Environmental Genomics
  1. By Value
6. Research
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Clinics
  1. By Value
3. Biotechnology and Pharmaceutical Companies
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Government
  1. By Value
6. Research Centers
  1. By Value
7. Academic and Government Institutes
  1. By Value
8. Others
  1. By Value
U.S.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Reagents and Consumables
    1. By Value
  4. Software and Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Next-Generation Sequencing
    1. By Value
  3. Sanger Sequencing
    1. By Value
  4. Third-Generation Sequencing
    1. By Value
  5. Single-Molecule Real-Time Sequencing
    1. By Value
  6. Others
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Diagnostics
    1. By Value
  3. Drug Discovery
    1. By Value
  4. Precision Medicine
    1. By Value
  5. Environmental Genomics
    1. By Value
  6. Research
    1. By Value
  7. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Clinics
    1. By Value
  3. Biotechnology and Pharmaceutical Companies
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Government
    1. By Value
  6. Research Centers
    1. By Value
  7. Academic and Government Institutes
    1. By Value
  8. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Reagents and Consumables
  1. By Value
4. Software and Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Next-Generation Sequencing
  1. By Value
3. Sanger Sequencing
  1. By Value
4. Third-Generation Sequencing
  1. By Value
5. Single-Molecule Real-Time Sequencing
  1. By Value
6. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Diagnostics
  1. By Value
3. Drug Discovery
  1. By Value
4. Precision Medicine
  1. By Value
5. Environmental Genomics
  1. By Value
6. Research
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Clinics
  1. By Value
3. Biotechnology and Pharmaceutical Companies
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Government
  1. By Value
6. Research Centers
  1. By Value
7. Academic and Government Institutes
  1. By Value
8. Others
  1. By Value
U.K.
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Reagents and Consumables
    1. By Value
  4. Software and Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Next-Generation Sequencing
    1. By Value
  3. Sanger Sequencing
    1. By Value
  4. Third-Generation Sequencing
    1. By Value
  5. Single-Molecule Real-Time Sequencing
    1. By Value
  6. Others
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Diagnostics
    1. By Value
  3. Drug Discovery
    1. By Value
  4. Precision Medicine
    1. By Value
  5. Environmental Genomics
    1. By Value
  6. Research
    1. By Value
  7. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Clinics
    1. By Value
  3. Biotechnology and Pharmaceutical Companies
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Government
    1. By Value
  6. Research Centers
    1. By Value
  7. Academic and Government Institutes
    1. By Value
  8. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Reagents and Consumables
  1. By Value
4. Software and Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Next-Generation Sequencing
  1. By Value
3. Sanger Sequencing
  1. By Value
4. Third-Generation Sequencing
  1. By Value
5. Single-Molecule Real-Time Sequencing
  1. By Value
6. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Diagnostics
  1. By Value
3. Drug Discovery
  1. By Value
4. Precision Medicine
  1. By Value
5. Environmental Genomics
  1. By Value
6. Research
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Clinics
  1. By Value
3. Biotechnology and Pharmaceutical Companies
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Government
  1. By Value
6. Research Centers
  1. By Value
7. Academic and Government Institutes
  1. By Value
8. Others
  1. By Value
China
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Reagents and Consumables
    1. By Value
  4. Software and Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Next-Generation Sequencing
    1. By Value
  3. Sanger Sequencing
    1. By Value
  4. Third-Generation Sequencing
    1. By Value
  5. Single-Molecule Real-Time Sequencing
    1. By Value
  6. Others
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Diagnostics
    1. By Value
  3. Drug Discovery
    1. By Value
  4. Precision Medicine
    1. By Value
  5. Environmental Genomics
    1. By Value
  6. Research
    1. By Value
  7. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Clinics
    1. By Value
  3. Biotechnology and Pharmaceutical Companies
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Government
    1. By Value
  6. Research Centers
    1. By Value
  7. Academic and Government Institutes
    1. By Value
  8. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Reagents and Consumables
  1. By Value
4. Software and Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Next-Generation Sequencing
  1. By Value
3. Sanger Sequencing
  1. By Value
4. Third-Generation Sequencing
  1. By Value
5. Single-Molecule Real-Time Sequencing
  1. By Value
6. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Diagnostics
  1. By Value
3. Drug Discovery
  1. By Value
4. Precision Medicine
  1. By Value
5. Environmental Genomics
  1. By Value
6. Research
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Clinics
  1. By Value
3. Biotechnology and Pharmaceutical Companies
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Government
  1. By Value
6. Research Centers
  1. By Value
7. Academic and Government Institutes
  1. By Value
8. Others
  1. By Value
UAE
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Reagents and Consumables
    1. By Value
  4. Software and Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Next-Generation Sequencing
    1. By Value
  3. Sanger Sequencing
    1. By Value
  4. Third-Generation Sequencing
    1. By Value
  5. Single-Molecule Real-Time Sequencing
    1. By Value
  6. Others
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Diagnostics
    1. By Value
  3. Drug Discovery
    1. By Value
  4. Precision Medicine
    1. By Value
  5. Environmental Genomics
    1. By Value
  6. Research
    1. By Value
  7. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Clinics
    1. By Value
  3. Biotechnology and Pharmaceutical Companies
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Government
    1. By Value
  6. Research Centers
    1. By Value
  7. Academic and Government Institutes
    1. By Value
  8. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product Type
1. Introduction
  1. Product Type By Value
2. Instruments
  1. By Value
3. Reagents and Consumables
  1. By Value
4. Software and Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Next-Generation Sequencing
  1. By Value
3. Sanger Sequencing
  1. By Value
4. Third-Generation Sequencing
  1. By Value
5. Single-Molecule Real-Time Sequencing
  1. By Value
6. Others
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Diagnostics
  1. By Value
3. Drug Discovery
  1. By Value
4. Precision Medicine
  1. By Value
5. Environmental Genomics
  1. By Value
6. Research
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals and Clinics
  1. By Value
3. Biotechnology and Pharmaceutical Companies
  1. By Value
4. Contract Research Organizations (CROs)
  1. By Value
5. Government
  1. By Value
6. Research Centers
  1. By Value
7. Academic and Government Institutes
  1. By Value
8. Others
  1. By Value
Brazil
1. By Product Type
  1. Introduction
    1. Product Type By Value
  2. Instruments
    1. By Value
  3. Reagents and Consumables
    1. By Value
  4. Software and Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Next-Generation Sequencing
    1. By Value
  3. Sanger Sequencing
    1. By Value
  4. Third-Generation Sequencing
    1. By Value
  5. Single-Molecule Real-Time Sequencing
    1. By Value
  6. Others
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Diagnostics
    1. By Value
  3. Drug Discovery
    1. By Value
  4. Precision Medicine
    1. By Value
  5. Environmental Genomics
    1. By Value
  6. Research
    1. By Value
  7. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals and Clinics
    1. By Value
  3. Biotechnology and Pharmaceutical Companies
    1. By Value
  4. Contract Research Organizations (CROs)
    1. By Value
  5. Government
    1. By Value
  6. Research Centers
    1. By Value
  7. Academic and Government Institutes
    1. By Value
  8. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Genome Sequencing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Illumina
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Thermo Fischer Scientific
Oxford Nanopore technology
Pacific Biosciences
F. Hoffmann-La Roche
PerkinElmer
Siemens Healthineers
Macrogen
Myriad Genetics
Cytiva
BioMatter
10x Genomics
BGI
MGI Tech

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment